A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
Clinical trial NCT06794866 · COMPLETED
Trial details
- NCT number
- NCT06794866
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-22
- Primary completion
- 2026-04-03
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.